WEN Will Guthy-Renker, Chaz Dean Put Hair-Loss Ordeal Behind Them?
This article was originally published in The Rose Sheet
WEN is “new” spelled backwards, but the safety scrutiny facing the hair-care brand is anything but. FDA continues to investigate related adverse-event reports, but 2017 could be the year that Guthy-Renker and Chaz Dean dispense with the lion’s share of consumer complaints and associated payouts.
You may also be interested in...
Direct seller launched a preemptive strike last year against a professional stylist for her allegations that Monat hair products cause hair loss and other damage "just like WEN." In recent weeks, the firm has lodged more defamation suits against individuals, while plaintiffs have begun filing proposed class actions against Monat in Florida federal court
The hair-care direct seller seeks injunctive relief and damages in a suit against a former sales rep who allegedly started the "Monat – My Modern Nightmare" Facebook group. According to Monat, there's no scientific or factual basis for defendant's claims that its products cause balding, hair loss and scalp damage.
L’Oreal failed in March to dismiss the majority of plaintiff claims in a putative class action alleging that the Soft-Sheen Carson Amla Legend hair relaxer is deceptively labeled and marketed, putting consumers at risk. According to plaintiffs’ latest amended complaint, the brand’s amla oil and “no lye” claims prepare users for a relatively gentle hair-smoothing experience, which has not been the case for many.